UBS Group’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.31M Buy
92,672
+59
+0.1% +$1.47K ﹤0.01% 3705
2025
Q1
$2.87M Buy
92,613
+11,522
+14% +$357K ﹤0.01% 3430
2024
Q4
$2.56M Buy
81,091
+66,539
+457% +$2.1M ﹤0.01% 3522
2024
Q3
$843K Buy
14,552
+4,465
+44% +$259K ﹤0.01% 3720
2024
Q2
$409K Sell
10,087
-25,268
-71% -$1.02M ﹤0.01% 4074
2024
Q1
$1.48M Sell
35,355
-3,985
-10% -$167K ﹤0.01% 3235
2023
Q4
$1.51M Buy
39,340
+28,729
+271% +$1.1M ﹤0.01% 3098
2023
Q3
$327K Sell
10,611
-42,001
-80% -$1.3M ﹤0.01% 3904
2023
Q2
$1.66M Buy
52,612
+37,145
+240% +$1.17M ﹤0.01% 2836
2023
Q1
$564K Buy
15,467
+5,690
+58% +$208K ﹤0.01% 3613
2022
Q4
$289K Buy
9,777
+8,442
+632% +$250K ﹤0.01% 4108
2022
Q3
$52K Buy
+1,335
New +$52K ﹤0.01% 5255
2022
Q1
Sell
-10,916
Closed -$802K 9687
2021
Q4
$802K Buy
10,916
+9,007
+472% +$662K ﹤0.01% 3607
2021
Q3
$174K Sell
1,909
-3,554
-65% -$324K ﹤0.01% 4375
2021
Q2
$343K Buy
5,463
+4,044
+285% +$254K ﹤0.01% 3995
2021
Q1
$38K Sell
1,419
-4,466
-76% -$120K ﹤0.01% 5796
2020
Q4
$108K Buy
5,885
+4,111
+232% +$75.4K ﹤0.01% 4656
2020
Q3
$32K Sell
1,774
-891
-33% -$16.1K ﹤0.01% 5098
2020
Q2
$44K Sell
2,665
-1,249
-32% -$20.6K ﹤0.01% 5127
2020
Q1
$51K Sell
3,914
-2,682
-41% -$34.9K ﹤0.01% 4934
2019
Q4
$121K Sell
6,596
-7,368
-53% -$135K ﹤0.01% 4881
2019
Q3
$246K Buy
13,964
+12,637
+952% +$223K ﹤0.01% 4205
2019
Q2
$22K Buy
1,327
+1,227
+1,227% +$20.3K ﹤0.01% 5683
2019
Q1
$2K Sell
100
-2,231
-96% -$44.6K ﹤0.01% 6638
2018
Q4
$46K Sell
2,331
-2,237
-49% -$44.1K ﹤0.01% 5270
2018
Q3
$101K Buy
4,568
+272
+6% +$6.01K ﹤0.01% 4727
2018
Q2
$111K Buy
4,296
+4,196
+4,196% +$108K ﹤0.01% 4497
2018
Q1
$2K Hold
100
﹤0.01% 6663
2017
Q4
$2K Buy
+100
New +$2K ﹤0.01% 6653